Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Deferred Tax (2015 - 2018)
Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly Long-Term Deferred Tax of $17.5 million for Q2 2018, down 28.87% year-over-year from $24.6 million in Q2 2017, and down 28.87% quarter-over-quarter from $24.6 million in Q2 2017.
Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Deferred Tax (2015 - 2018) Analysis & Trends
Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $17.5 million for Q2 2018.
- In Q2 2018, Long-Term Deferred Tax fell 28.87% year-over-year to $17.5 million; the TTM figure through May 2018 stood at $17.5 million (down 28.87% YoY), while the FY2018 annual figure was $17.5 million, down 28.87% from the prior year.
- Long-Term Deferred Tax for Q2 2018 stood at $17.5 million, down from $24.6 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $32.2 million in Q2 2015, with the low at $17.5 million in Q2 2018.
- The 4-year median for Long-Term Deferred Tax is $23.5 million (2016), against an average of $24.2 million.
- The sharpest annual moves came in 2016 and 2017: Long-Term Deferred Tax tumbled 30.37% in 2016, then grew 9.53% in 2017.
- Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax stood at $32.2 million in 2015, then sank by 30.37% to $22.4 million in 2016, then gained by 9.53% to $24.6 million in 2017, then decreased by 28.87% to $17.5 million in 2018.
- Business Quant data shows LFCR's Long-Term Deferred Tax at $17.5 million in Q2 2018, $24.6 million in Q2 2017, and $22.4 million in Q2 2016.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 27, 2018 | 17.49 Mn |
| May 28, 2017 | 24.58 Mn |
| May 29, 2016 | 22.44 Mn |
| May 31, 2015 | 32.23 Mn |